Shortening the Alzheimer's disease assessment scale cognitive subscale.

Stephen Z Levine Yair Goldberg Anat Rotstein Myrto T Samara Kazufumi Yoshida Andrea Cipriani Takeshi Iwatsubo Stefan Leucht Toshiaki A Furawaka

Published in: European psychiatry : the journal of the Association of European Psychiatrists (2024)

IRT identified a short ADAS-cog version that separated donepezil and placebo, suggesting its clinical potential for assessment and treatment monitoring.

Keyphrases

cognitive decline
risk assessment
human health
study protocol
smoking cessation
open label
placebo controlled